• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Sony, Olympus launch medical device joint venture

Sony, Olympus launch medical device joint venture

April 16, 2013
CenterWatch Staff

Sony and Olympus have launched Sony Olympus Medical Solutions, a medical business venture that aims to align Sony's cutting-edge electronics technologies in areas such as digital imaging with Olympus' manufacturing and R&D expertise in the area of medical products including lenses and optical technologies in order to bring high-quality medical care to as many people as possible, and contribute to medical advancement worldwide.

Sony Olympus Medical Solutions plans to develop, design, manufacture, and market new innovative medical products such as surgical endoscopes and related systems and also plans to establish a new medical and imaging systems solutions business to deliver comprehensive solutions for operating rooms worldwide.

The new venture’s logo symbolizes the integration between the two companies and the innovation Sony Olympus Medical Solutions aims to bring to the field of medical surgery resulting in comfort and wellness to patients, doctors and people all over the world.

“At Sony, we are targeting the medical business for mid- to long-term growth, and we have been engaged in several initiatives to expand this business,” said Kazuo Hirai, president and CEO, Sony. “By integrating these with Olympus' wealth of knowledge and expertise in medical technologies and business, I am confident the new company will bring innovation to the medical industry and achieve great success.”

Hiroyuki Sasa, representative director and president, Olympus, said, “In establishing this joint venture with Sony, a world leader in imaging technology, we have taken a step toward the future of medical treatment. The medical business is a driver for profit and growth at Olympus, and we have targeted the ‘drastic growth of our surgical business’ as a key strategy. By combining the two companies' technologies and taking maximum advantage of the resulting synergies, I believe we will be able to make a contribution to world medical progress through innovative new medical devices developments that Olympus could not achieve on its own.”

Upcoming Events

  • 26Jan

    Reducing Complexity in Starting Clinical Trials – More Patients, Faster Startup

  • 27Jan

    Medical Device Clinical Trials in China: Latest Regulatory Developments

  • 11Feb

    Lab X.0: Addressing Quality and Compliance Challenges in Laboratory Operations in the COVID-19 All-Digital Era

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 26Apr

    MAGI's Clinical Research vConference — Spring 2021

Featured Products

  • Regenerative Medicine – Steps to Accelerate Development : PDF

    Regenerative Medicine: Steps to Accelerate Development

  • Clinical Trial Agreements — A Guide to Key Words and Phrases : PDF

    Clinical Trial Agreements: A Guide to Key Words and Phrases

Featured Stories

  • TechInnovation-360x240.png

    Pace of Technology Innovation in Trials Could Slow After Pandemic Eases

  • AskTheExperts-360x240.png

    Ask the Experts: Certifying and Maintaining Copies of Original Source Documents

  • Resources-360x240.png

    Trial Complexity, Endpoints Continue to Increase, Stretching Site Resources

  • FocusinRed-360x240.png

    Return to Focus on Risk Management Postpandemic Could Prove Challenging to Sites

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell My Personal Information

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing